Ipratropium
"Ipratropium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
Descriptor ID |
D009241
|
MeSH Number(s) |
D02.145.074.722.229.400 D03.132.760.180.572.400 D03.132.889.180.648.400 D03.605.084.500.722.229.400 D03.605.869.229.400
|
Concept/Terms |
Ipratropium- Ipratropium
- (endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
- N-Isopropylatropine
- N Isopropylatropine
Ipratropium Bromide- Ipratropium Bromide
- Ipratropium Bromide Monohydrate
- Bromide Monohydrate, Ipratropium
- Monohydrate, Ipratropium Bromide
|
Below are MeSH descriptors whose meaning is more general than "Ipratropium".
Below are MeSH descriptors whose meaning is more specific than "Ipratropium".
This graph shows the total number of publications written about "Ipratropium" by people in this website by year, and whether "Ipratropium" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2013 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ipratropium" by people in Profiles.
-
Navanandan N, Federico M, Mistry RD. Positive Expiratory Pressure for the Treatment of Acute Asthma Exacerbations: A Randomized Controlled Trial. J Pediatr. 2017 06; 185:149-154.e2.
-
Schauer SG, Cuenca PJ, Johnson JJ, Ramirez S. Management of acute asthma in the emergency department. Emerg Med Pract. 2013 Jun; 15(6):1-28.
-
VanderSchaaf K, Olson KL, Billups S, Hartsfield CL, Rice M. Self-reported inhaler use in patients with chronic obstructive pulmonary disease. Respir Med. 2010 Jan; 104(1):99-106.
-
Balkissoon R, Make B. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. COPD. 2008 Aug; 5(4):221-7.
-
Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther. 2007 Jun; 29(6):1203-13.
-
Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.
-
Rascati KL, Stanford RH, Borker R. A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination. Clin Ther. 2005 Mar; 27(3):346-54.
-
Diamond L, Dockhorn RJ, Grossman J, Kisicki JC, Posner M, Zinny MA, Koker P, Korts D, Wecker MT. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1139-46.
-
Zaragoza RH, Szefler SJ, Bratton DL. Brief report: therapeutic manipulations in severe nocturnal asthma. A nonconventional approach in a severe high-risk asthmatic. J Asthma. 1992; 29(4):281-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|